For the “signaling by receptor tyrosine kinases” pathway, several studies have suggested that high levels of receptor tyrosine kinases (RTKs) may be associated with increased breast cancer aggressiveness and decreased overall and disease-free survival [55–60]. This evidence concerns the gene NTRK1 and breast carcinoma.